Detalhe da pesquisa
1.
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
Clin Breast Cancer
; 18(4): 289-297, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29153866